Axiome

San Francisco, United States Founded: 2022 • Age: 4 yrs
High-throughput electronic biosensors are developed for drug discovery and diagnostics.

About Axiome

Axiome is a company based in San Francisco (United States) founded in 2022 by Samarth Athreya. It operates as a HealthTech. Axiome offers products and services including Electronic Biosensors. Axiome operates in a competitive market with competitors including Cardea Bio, Hememics Biotechnologies, Nix, Aligned Bio and Monod, among others.

  • Headquarter San Francisco, United States
  • Founders Samarth Athreya
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Axiome

Axiome offers a comprehensive portfolio of products and services, including Electronic Biosensors. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Electronic biosensors are developed for drug discovery applications.

Funding Insights of Axiome

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Axiome

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Axiome

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Axiome Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Axiome

Axiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardea Bio, Hememics Biotechnologies, Nix, Aligned Bio and Monod, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital graphene biosensors are developed using machine learning.
domain founded_year HQ Location
Biopreservation platform for mammalian cells and biologics is developed.
domain founded_year HQ Location
Sweat-based biosensors are provided for body hydration monitoring.
domain founded_year HQ Location
Nanowire-based sensors and alignment technologies are provided for molecular detection.
domain founded_year HQ Location
Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules
domain founded_year HQ Location
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Axiome

Frequently Asked Questions about Axiome

When was Axiome founded?

Axiome was founded in 2022.

Where is Axiome located?

Axiome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Who is the current CEO of Axiome?

Samarth Athreya is the current CEO of Axiome. They have also founded this company.

What does Axiome do?

Axiome is engaged in the development of low-cost, high-throughput electronic biosensors. These are utilized to support drug discovery and point-of-care molecular diagnostics. The company operates within the biotechnology sector, aiming to advance healthcare solutions through innovative sensor technology.

Who are the top competitors of Axiome?

Axiome's top competitors include Nix, Olaris and Monod.

What products or services does Axiome offer?

Axiome offers Electronic Biosensors.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available